Loading...

Presentation



VISION & INNOVATION:
Where excellence drives the future of gynecologic oncology
A high-level international meeting bringing together clinical leaders, researchers, and industry partners to shape the next decade of gynecologic oncology through innovation, evidence, and legacy.
foto tributo


About the Meeting
Vision & Innovation is an international meeting that brings together leading voices in gynecologic oncology around a dual purpose: advancing evidence-based clinical innovation while honoring the scientific and editorial legacy of Prof. Pedro T. Ramírez, a key figure in the contemporary evolution of the specialty. Over two days, the program combines advanced surgery, medical oncology, translational science, and artificial intelligence with a humanistic perspective focused on patients, quality of life, and the major challenges shaping the 2025–2035 horizon. Designed as a high-level forum oriented toward real-world implementation, Vision & Innovation connects clinical leaders, academics, and industry partners with a shared goal: transforming evidence into practice and helping define the future of gynecologic oncology.


Key Topics:
  • Future standards in gynecologic oncology surgery and advanced clinical decision-making.
  • Breakthrough therapies and translational science shaping real-world practice.
  • Artificial intelligence driving the next paradigm in diagnosis, surgery, and research.
  • Patient-centered innovation: fertility, menopause, survivorship, and quality of life.
  • Value, sustainability, and global challenges in modern oncology care.
  • Training, leadership, and the legacy of the next generation.
  • Scientific publishing, editorial vision, and the evolving role of IJGC.


A Tribute & A Vision: Honoring the legacy of Prof. Pedro T. Ramírez while exploring the future of gynecologic oncology through innovation, scientific excellence, and a humanistic approach to patient care.


Audience Target: Profile of attendees with high capacity for clinical, academic, and training influence (content directed at advanced practice):
  • Gynecologic oncologists and high-complexity surgeons (pelvis/retroperitoneum/upper abdomen).
  • Medical oncologists dedicated to gynecologic tumors.
  • Radiation oncologists and pathologists dedicated to gynecologic tumors.
  • Multidisciplinary teams: oncology nursing, psycho-oncology, rehabilitation and prehabilitation/ERAS.
  • Fellows and residents (legacy, training, and future leadership).
  • Clinical directors and managers involved in centralization, quality, and health outcomes.


Meeting Format: In-person symposium over two days with plenary sessions organized by thematic blocks, implementation-oriented debates, and networking spaces.
The design promotes interaction between speakers, moderators, and attendees, as well as the transfer of knowledge to real practice.


Organizing Committee:
  • Dr. Enrique Chacón Cruz, Cancer Center Clínica Universidad de Navarra, Pamplona, Spain
  • Dr. Arthur Hsu, National Taiwan University Hospital, Taipei, Taiwan
  • Dr. José Ángel Mínguez Milio, Cancer Center Clínica Universidad de Navarra, Pamplona, Spain
  • Dr. Antonio González-Martín, Cancer Center Clínica Universidad de Navarra, Madrid, Spain
  • Dr. Luis Chiva de Agustín, Cancer Center Clínica Universidad de Navarra, Madrid, Spain


Organized by:

logo organizador


Endorsed by:

logo organizador logo organizador